Re-introduction of biological DMARDs for rheumatoid arthritis during active antibiotic therapy for prosthetic joint infections
The safety of treating active rheumatoid arthritis (RA) with bDMARDS in patients with joint or other infections is uncertain. The authors report and discuss three patients with RA who developed joint infection after orthopaedic surgery and who received biological DMARDS as well as antibiotics. The cases shed light on the safety of this approach to management.
